Short answer
MERIT MEDICAL SYSTEMS INC (MMSI) filed its Q3 2026 10-Q quarterly report on Oct 29, 2026 for the quarter ended Sep 30, 2026. Quarterly revenue was $416M (up 8.4% year over year) with net income of $42M.
Q3 2026 key financials · XBRL
- Revenue
- $416M
- +8.4% YoY · −0.6% QoQ
- Net income
- $42M
- +52.4% YoY · +9.0% QoQ
- Operating margin
- 14.1%
- Gross margin
- 48.2%
- EPS (diluted)
- $0.70
- +52.2% YoY · +7.7% QoQ
Source: XBRL data from the MERIT MEDICAL SYSTEMS INC (MMSI) Q3 2026 10-Q on SEC EDGAR. USD.
MERIT MEDICAL SYSTEMS INC Q3 2026 10-Q analysis
AI summary of MD&A and risk factor updates
Management Discussion & Analysis
- Revenue $416.2M, up 8.4% YoY from $384.2M
- Net margin 10.2% vs 7.2%; operating margin 14.1% vs 11.1% YoY
- Best platform Endoscopy, $23.4M, up 32.9%; worst Procedural Solutions, $27.2M, down 15.9%
- Cash $505.8M vs $448.5M; operating cash flow $175.2M vs $198.9M
- View Point sales launched; 2026 capital spending expected at $60M to $70M, with supply delays and tariff risks തുടര
Risk Factors
- Newly added geopolitical risk: U.S.-Israel-Iran conflict escalation threatens energy supplies, supply chains, and petroleum-based input costs
- Most materially updated financial risk: $700 million revolving commitment may increase leverage-covenant pressure and reduce cash for operations
- Debt compliance risk: covenant breach could accelerate $747.5 million of 3.00% Convertible Notes due 2029
- Operational risk: higher resin and petroleum-based material costs from disrupted global energy markets
- Liquidity risk: secured-credit-agreement default could trigger collateral foreclosure and impair capital-expenditure funding
Generated from the filing text; verify against the original. 10-K vs 10-Q vs 8-K
Other MERIT MEDICAL SYSTEMS INC quarterly reports
Ask about this quarter
Compare quarters, check guidance or see what insiders and funds did around the report.